Paper35580441
Eriodictyol inhibits breast carcinogenesis by targeting circ_0007503 and repressing PI3K/Akt pathway.
He J and 4 others. Phytomedicine, 2022. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Eriodictyol inhibits breast carcinogenesis by targeting circ_0007503 and repressing PI3K/Akt pathway. Papers, record 35580441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35580441
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Eriodictyol inhibits breast carcinogenesis by targeting circ_0007503 and repressing PI3K/Akt pathway.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Flavanones | Major topic |
| MicroRNAs | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Animals | |
| Carcinogens, Environmental | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Cell Transformation, Neoplastic | |
| Female | |
| Humans | |
| Rats | |
| Signal Transduction |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943257 | Mechanisms and Therapeutic Advances of Natural Products Regulating Non-Coding RNAs in Cancer. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943257 | PubMed |
| 41977114 | Eriodictyol in Cancer Therapy: Reviewing Mechanistic Insights and Translational Opportunities. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977114 | PubMed |
| 40918151 | CircASH1L-mediated tumor progression in triple-negative breast cancer: PI3K/AKT pathway mechanisms. | Open Med (Wars) | 2025 | https://conductscience.org/library/papers/40918151 | PubMed |
| 40796179 | Natural Antioxidants as Regulators of Circular RNA Expression and Function. | Wiley Interdiscip Rev RNA | 2025 | https://conductscience.org/library/papers/40796179 | PubMed |
| 40740483 | PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40740483 | PubMed |
| 40155922 | Integrative network pharmacology, transcriptomics, and proteomics reveal the material basis and mechanism of the Shen Qing Weichang Formula against gastric cancer. | Chin Med | 2025 | https://conductscience.org/library/papers/40155922 | PubMed |
| 39953537 | Eriodictyol-cisplatin coated nanomedicine synergistically promote osteosarcoma cells ferroptosis and chemosensitivity. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/39953537 | PubMed |
| 39296640 | Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/39296640 | PubMed |
| 37240225 | Optimized De Novo Eriodictyol Biosynthesis in Streptomyces albidoflavus Using an Expansion of the Golden Standard Toolkit for Its Use in Actinomycetes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240225 | PubMed |
| 36838870 | Potential of Tamarind Shell Extract against Oxidative Stress In Vivo and In Vitro. | Molecules | 2023 | https://conductscience.org/library/papers/36838870 | PubMed |
| 36551742 | Natural Blockers of PD-1/PD-L1 Interaction for the Immunotherapy of Triple-Negative Breast Cancer-Brain Metastasis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36551742 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35580441
GET https://conductscience.org/api/papers/v1/35580441/authors